Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

Prehabilitation for Adults With End Stage Renal Disease on the Kidney Transplant Waitlist
Prehabilitation for Adults With End Stage Renal Disease on the Kidney Transplant Waitlist
Status: Enrolling
Updated:  4/17/2018
mi
from
Lutherville, MD
Prehabilitation for Adults With End Stage Renal Disease on the Kidney Transplant Waitlist
Prehabilitation for Adults With End Stage Renal Disease on the Kidney Transplant Waitlist
Status: Enrolling
Updated: 4/17/2018
Johns Hopkins Physical Medicine and Rehabilitation
mi
from
Lutherville, MD
Click here to add this to my saved trials
Treatment of Uremic Pruritus With PA101B
Treatment of Uremic Pruritus With Inhaled PA101B in Patients With End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated:  4/18/2018
mi
from
Phoenix, AZ
Treatment of Uremic Pruritus With PA101B
Treatment of Uremic Pruritus With Inhaled PA101B in Patients With End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated: 4/18/2018
Arizona Kidney Disease and Hypertension Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Treatment of Uremic Pruritus With PA101B
Treatment of Uremic Pruritus With Inhaled PA101B in Patients With End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated:  4/18/2018
mi
from
Pine Bluff, AR
Treatment of Uremic Pruritus With PA101B
Treatment of Uremic Pruritus With Inhaled PA101B in Patients With End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated: 4/18/2018
U.S. Renal Care Inc
mi
from
Pine Bluff, AR
Click here to add this to my saved trials
Treatment of Uremic Pruritus With PA101B
Treatment of Uremic Pruritus With Inhaled PA101B in Patients With End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated:  4/18/2018
mi
from
Northridge, CA
Treatment of Uremic Pruritus With PA101B
Treatment of Uremic Pruritus With Inhaled PA101B in Patients With End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated: 4/18/2018
Valley Renal Medical Group
mi
from
Northridge, CA
Click here to add this to my saved trials
Treatment of Uremic Pruritus With PA101B
Treatment of Uremic Pruritus With Inhaled PA101B in Patients With End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated:  4/18/2018
mi
from
San Dimas, CA
Treatment of Uremic Pruritus With PA101B
Treatment of Uremic Pruritus With Inhaled PA101B in Patients With End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated: 4/18/2018
North America Research Institute Inc.
mi
from
San Dimas, CA
Click here to add this to my saved trials
Treatment of Uremic Pruritus With PA101B
Treatment of Uremic Pruritus With Inhaled PA101B in Patients With End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated:  4/18/2018
mi
from
Pembroke Pines, FL
Treatment of Uremic Pruritus With PA101B
Treatment of Uremic Pruritus With Inhaled PA101B in Patients With End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated: 4/18/2018
Pines Clinical Research, Inc.
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Treatment of Uremic Pruritus With PA101B
Treatment of Uremic Pruritus With Inhaled PA101B in Patients With End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated:  4/18/2018
mi
from
Tampa, FL
Treatment of Uremic Pruritus With PA101B
Treatment of Uremic Pruritus With Inhaled PA101B in Patients With End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated: 4/18/2018
Genesis Clinical Research, Inc.
mi
from
Tampa, FL
Click here to add this to my saved trials
Treatment of Uremic Pruritus With PA101B
Treatment of Uremic Pruritus With Inhaled PA101B in Patients With End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated:  4/18/2018
mi
from
Meridian, ID
Treatment of Uremic Pruritus With PA101B
Treatment of Uremic Pruritus With Inhaled PA101B in Patients With End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated: 4/18/2018
Boise Kidney and Hypertension Institute
mi
from
Meridian, ID
Click here to add this to my saved trials
Treatment of Uremic Pruritus With PA101B
Treatment of Uremic Pruritus With Inhaled PA101B in Patients With End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated:  4/18/2018
mi
from
Evergreen Park, IL
Treatment of Uremic Pruritus With PA101B
Treatment of Uremic Pruritus With Inhaled PA101B in Patients With End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated: 4/18/2018
Fresenius Medical Care of Evergreen Park
mi
from
Evergreen Park, IL
Click here to add this to my saved trials
Treatment of Uremic Pruritus With PA101B
Treatment of Uremic Pruritus With Inhaled PA101B in Patients With End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated:  4/18/2018
mi
from
Albuquerque, NM
Treatment of Uremic Pruritus With PA101B
Treatment of Uremic Pruritus With Inhaled PA101B in Patients With End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated: 4/18/2018
Renal Medicine Associates
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Treatment of Uremic Pruritus With PA101B
Treatment of Uremic Pruritus With Inhaled PA101B in Patients With End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated:  4/18/2018
mi
from
Gallup, NM
Treatment of Uremic Pruritus With PA101B
Treatment of Uremic Pruritus With Inhaled PA101B in Patients With End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated: 4/18/2018
US Renal Care
mi
from
Gallup, NM
Click here to add this to my saved trials
Treatment of Uremic Pruritus With PA101B
Treatment of Uremic Pruritus With Inhaled PA101B in Patients With End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated:  4/18/2018
mi
from
Ridgewood, NY
Treatment of Uremic Pruritus With PA101B
Treatment of Uremic Pruritus With Inhaled PA101B in Patients With End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated: 4/18/2018
Ridgewood Dialysis Center
mi
from
Ridgewood, NY
Click here to add this to my saved trials
Treatment of Uremic Pruritus With PA101B
Treatment of Uremic Pruritus With Inhaled PA101B in Patients With End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated:  4/18/2018
mi
from
Chattanooga, TN
Treatment of Uremic Pruritus With PA101B
Treatment of Uremic Pruritus With Inhaled PA101B in Patients With End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated: 4/18/2018
Southeast Renal Research Institute
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Treatment of Uremic Pruritus With PA101B
Treatment of Uremic Pruritus With Inhaled PA101B in Patients With End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated:  4/18/2018
mi
from
Winston-Salem, NC
Treatment of Uremic Pruritus With PA101B
Treatment of Uremic Pruritus With Inhaled PA101B in Patients With End-Stage Renal Disease Requiring Hemodialysis
Status: Enrolling
Updated: 4/18/2018
Brookview Hills Research Associates, LLC
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease
The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease
Status: Enrolling
Updated:  4/19/2018
mi
from
Bronx, NY
The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease
The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease
Status: Enrolling
Updated: 4/19/2018
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Alkali Therapy in Chronic Kidney Disease
Placebo-controlled Randomized Clinical Trial of Alkali Therapy in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  4/19/2018
mi
from
Bronx, NY
Alkali Therapy in Chronic Kidney Disease
Placebo-controlled Randomized Clinical Trial of Alkali Therapy in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 4/19/2018
Albert Einstein College of Medicine
mi
from
Bronx, NY
Click here to add this to my saved trials
Alkali Therapy in Chronic Kidney Disease
Placebo-controlled Randomized Clinical Trial of Alkali Therapy in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  4/19/2018
mi
from
Cleveland, OH
Alkali Therapy in Chronic Kidney Disease
Placebo-controlled Randomized Clinical Trial of Alkali Therapy in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 4/19/2018
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
Effects of Vitamin D and Fish Oil on the Kidney in Hypertensives
Effects of Vitamin D and Fish Oil on the Kidney in Hypertensives
Status: Enrolling
Updated:  4/19/2018
mi
from
Boston, MA
Effects of Vitamin D and Fish Oil on the Kidney in Hypertensives
Effects of Vitamin D and Fish Oil on the Kidney in Hypertensives
Status: Enrolling
Updated: 4/19/2018
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Birmingham, AL
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Nephrology Associates, P.C.
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Birmingham, AL
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Huntsville, AL
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Nephrology Consultants
mi
from
Huntsville, AL
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Mobile, AL
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Alabama Medical Group, P.C.
mi
from
Mobile, AL
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Peoria, AZ
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
AKDHC Medical Research Service
mi
from
Peoria, AZ
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Phoenix, AZ
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Arizona Kidney Disease and Hyp
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Phoenix, AZ
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Phoenix VA Healthcare
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Prescott, AZ
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
AKDHC Medical Research Service
mi
from
Prescott, AZ
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Tucson, AZ
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
AKDHC Med Res Services LLC
mi
from
Tucson, AZ
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Little Rock, AR
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
B.G. Clinical Research Center
mi
from
Little Rock, AR
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Alhambra, CA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Sakhrani, Alhambra, CA.
mi
from
Alhambra, CA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Azusa, CA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
North America Research Institu
mi
from
Azusa, CA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Bakersfield, CA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Natl Inst Clinical Research
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Chula Vista, CA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
California Institute Renal Res
mi
from
Chula Vista, CA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Chula Vista, CA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
San Diego Coastal Endocrinolog
mi
from
Chula Vista, CA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Downey, CA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Rancho Los Amigos National Reh
mi
from
Downey, CA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Fullerton, CA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
St. Jude Hospital
mi
from
Fullerton, CA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Glendale, CA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
California Renal Res Network
mi
from
Glendale, CA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Lancaster, CA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
High Desert Nephrology Associa
mi
from
Lancaster, CA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Loma Linda, CA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
VA Loma Linda
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Los Angeles, CA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Academic Med Research Inst Inc
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Los Angeles, CA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Axis Clinical Trials
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Los Angeles, CA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
National Research Institute
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Los Angeles, CA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Los Angeles, CA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Facey Medical Foundation
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
North Hollywood, CA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Providence Clinical Research
mi
from
North Hollywood, CA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Norwalk, CA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Lucita M. Cruz,Md.,Inc.
mi
from
Norwalk, CA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Orange, CA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Diabetes Associates Medical Gr
mi
from
Orange, CA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Palm Springs, CA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Desert Medical Group Inc.
mi
from
Palm Springs, CA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Paramount, CA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Mohammed Ismail, MD, Inc.
mi
from
Paramount, CA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Porterville, CA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Sierra View Nephrology Inc
mi
from
Porterville, CA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Rialto, CA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Inland Empire Liver Foundation
mi
from
Rialto, CA
Click here to add this to my saved trials